Missouri judge approves Bayer’s $7.25 billion Roundup settlement

A Missouri judge gave final approval to Bayer AG’s proposal to pay up to $7.25 billion to settle U.S. lawsuits alleging its Roundup weedkiller causes cancer. The settlement covers roughly 65,000 current and future claims and offers payouts ranging from $10,000 to $165,000 per claimant. Bayer had previously spent about $10 billion in 2020 on earlier Roundup litigation and had been unable to secure court approval for a $1.25 billion parallel settlement. The approval follows a recent Supreme Court ruling in Bayer’s favor and a jury verdict that lifted the company’s shares.

The settlement caps Bayer’s future liability for Roundup cancer claims, removing a major legal uncertainty and potentially supporting its share price. The company will need to fund payouts of up to $7.25 billion, which will affect cash flow and balance‑sheet allocations.

  • 1A Missouri judge approved Bayer’s $7.25 billion settlement of Roundup cancer lawsuits.
  • 2The settlement aims to resolve approximately 65,000 claims in U.S. state and federal courts.
  • 3Payouts under the deal range from $10,000 to $165,000 per claimant.
  • 4Bayer previously spent about $10 billion in 2020 to resolve most existing Roundup lawsuits.
  • 5Bayer was unable to obtain court approval for a $1.25 billion settlement that would have covered future claims.
  • 6Bayer’s shares rose after a recent jury verdict in its favor.

Sources